USE OF RECOMBINANT ADENOVIRAL VECTORS OF NON-HUMAN ANIMAL ORIGIN FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR GENE THERAPY

摘要

PCT No. PCT/FR94/00531 Sec. 371 Date Nov. 29, 1995 Sec. 102(e) Date Nov. 29, 1995 PCT Filed May 6, 1994 PCT Pub. No. WO94/26914 PCT Pub. Date Nov. 24, 1994The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.